Focal Radiofrequency Ablation of Barrett's Esophagus as Add-On Treatment After Endoscopic Resection and HALO 360 Treatment

AbstractRadiofrequency ablation (RFA) has become the first-choice treatment for dysplastic Barrett's esophagus. RFA is indicated for flat high-grade dysplasia and for eradication of residual Barrett's esophagus after endoscopic resection of any visible lesion containing high-grade dysplasia or an early mucosal cancer. RFA has a high success rate for eradication of dysplasia in 95% of patients. Eradication of intestinal metaplasia can be obtained in approximately 80% of patients. This result can, however, only be obtained by a multiple step therapy with circumferential and subsequent focal ablation (HALO 90). This article is part of an expert video encyclopedia